Edition:
United States

pSivida Corp (PSDV.OQ)

PSDV.OQ on NASDAQ Stock Exchange Global Market

1.80USD
2 Dec 2016
Change (% chg)

$0.03 (+1.69%)
Prev Close
$1.77
Open
$1.77
Day's High
$1.81
Day's Low
$1.71
Volume
62,176
Avg. Vol
22,048
52-wk High
$5.80
52-wk Low
$1.71

Select another date:

Mon, Nov 7 2016

BRIEF-PSivida Corp posts Q1 loss per share $0.21

* Psivida Corp reports fiscal 2017 first quarter results and provides update on corporate objectives & milestone timeline

BRIEF-Psivida board increases the number of directors of the board to 6

* On September 26, 2016, the board increased the number of directors of the board to six Source text - http://bit.ly/2cCOg5C Further company coverage:

BRIEF-Psivida Corp reports Q4 loss per share $0.19

* Psivida Corp provides company update and reports fourth quarter and FY 2016 results

BRIEF-Psivida announces 13 new patents issued or allowed

* Says an additional 108 applications are pending in U.S. and foreign jurisdictions Source text for Eikon: Further company coverage:

BRIEF-pSivida to consolidate all R&D in current U.S. facility

* pSivida Corp announces plan to consolidate all research and development in current U.S. facility

BRIEF-pSivida reports positive results from investigator-sponsored phase 2 study of Medidur

* Results from investigator-sponsored phase 2 study of Medidur showed no recurrence of uveitis in 11 eyes treated with Medidur in 2 years after implant Source text for Eikon: Further company coverage:

BRIEF-pSivida completes two preclinical studies testing Durasert technology

* pSivida announces successful completion of two preclinical studies of Durasert sustained-release insert delivering repurposed cancer drug to treat wet amd Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)

Select another date: